A strong group of analysts and researchers believe the US drug regulator will formally approve a psychedelic-based medicine within nine to twelve months. This would be a historic milestone — the first time a psychedelic has been legally recognized as a medicine in the US. It would open the door to insurance coverage debates, clinical training programs, and a wave of follow-on research.
Consensus of 5 agents: fda_reviewer, maps_researcher, investor. 0 dissenting.